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Abstract
Background: It is estimated that nearly 600,000 cancer cases in the UK could have been avoided in the past five
years if people had healthier lifestyles. A number of theories of behaviour change suggest that before people will
change health behaviours, they must accept that a risk applies to them. This study aimed to explore the views of
the public on receiving personalised cancer risk information and the potential for that information to motivate
behaviour change.
Methods: We conducted 27 interviews with members of the public (mean age 49 ± 23 years). Each participant
completed a questionnaire to allow calculation of their risk of developing the most common cancers (10 for
women, 8 for men). During the interviews we presented their risk using a web-based tool developed for the study
and discussions covered their views on receiving that information. Each interview was audio-recorded and then
analysed using thematic analysis.
Results: Participants generally viewed the concept of personalised cancer risk positively. The first reaction of almost
all when presented with their 10-year risk of an individual cancer without any further context was that it was low
and not concerning. Views on what constituted a high risk ranged widely, from 0.5 to 60%. All felt seeing the
impact of changes in lifestyle was helpful. For some this led to intentions to change behaviour, but reductions
in risk were not always motivating as the risks were considered low and differences small.
Conclusions: Provision of personalised cancer risk was well received and may be a useful addition to other cancer
prevention initiatives. Further work is needed in particular to develop ways to present cancer risk that reflect the
general perception of what constitutes a risk high enough to motivate behaviour change and help patients
contextualise a less well known health risk by providing a frame of reference.
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Background
Up to 40% of all cases of cancer are potentially prevent-
able through changes to lifestyle factors such as smoking,
alcohol consumption, diet, weight and physical activity
[1]. We know from evidence, however, that only 3% of the
general public are aware that being overweight can
increase their risk of cancer, less than a third are aware
that physical activity could help reduce risk [2–5], and one
in seven people believe that lifetime risk of cancer is
unmodifiable [6]. Additionally, when asked to estimate
their risk of cancer, many individuals have incorrect risk
perceptions [7–9].
A number of behaviour change theories, including
Protection Motivation Theory [10] and the Extended
Parallel Process Model [11], suggest that providing in-
dividuals with their estimated risk of developing cancer
and demonstrating the impact of lifestyle change on
that future risk may motivate change at an individual
level through increases in accuracy of risk perception
and response efficacy [12]. This could then complement
wider collective approaches to shifting population dis-
tributions of behaviour and risk factors. A number of
risk tools are now available which predict an individ-
ual’s future risk of cancer and which could be used for
this purpose [13–21]. Previous research has confirmed
that providing cancer risk information to individuals
can improve accuracy of risk perception [9, 22, 23] and
enhance response efficacy [24] and intention to have
cancer screening [25, 26]. However, most studies
exploring preferences for formats of presentation and
responses to cancer risk information have used hypo-
thetical cases [27–30] and there remains uncertainty
over the views of the general public on being offered
their own cancer risk and how best to present risk to
promote understanding and motivate behaviour change.
Unlike similar risk tools for other conditions, such as
QRisk2® [31] for cardiovascular disease, these tools are
also rarely used in routine healthcare settings [32].It is
therefore not clear how best to incorporate risk assess-
ment into practice to maximise benefits whilst mini-
mising harms.
The aim of this study was to address some of these
uncertainties by exploring the reactions of members of
the general public to different presentations of estimates
of their own personalised cancer risk and their views on
whether such information should be incorporated into
routine medical practice.
Methods
Face-to-face interviews were conducted with members
of the public in Cambridge, UK. Ethical approval was
obtained from the East of England Cambridgeshire and
Hertfordshire Research Ethics Committee (reference 15/
EE/0310). All participants provided written consent.
Participants and recruitment
To enable us to include individuals with a range of back-
grounds and of different ages we used three recruitment
strategies: 1) posters in the waiting rooms of ten Primary
Care Practices across Cambridgeshire; 2) letters of invi-
tation and the participant information leaflet sent via the
lead of the group to a local patient participation group;
and 3) letters of invitation and the participant informa-
tion leaflet sent by Practice staff to 100 randomly se-
lected patients aged between 18 and 65 years and
registered at one Primary Care Practice in Cambridge-
shire. By sending letters of invitation to a local patient
participation group and to individual patients at one Pri-
mary Care practice, we were able to reach potential par-
ticipants who may not have accessed healthcare during
the recruitment period. For those responding to the
posters or invitation letters via the patient participation
group, no age limits were applied. The letters of invita-
tion to individual patients were sent out part way
through recruitment and the decision to limit to an
upper age of 65 years was made to purposively sample
younger people. In all cases those interested in taking
part in the study were invited to contact the research
team and all those who completed the pre-interview
questionnaire and agreed to an interview were included
in the study. Letters of invitation to patients registered
at the Primary Care Practice were sent out in batches of
20 and we continued recruitment until we reached data
saturation.
Pre-interview questionnaire
Prior to the interviews, participants provided their address
and were posted a screening questionnaire asking about
their risk factors for cancer. This included questions about
age, sex, family history of cancer, medical history and
lifestyle factors such as smoking, alcohol consumption,
diet, weight and physical activity. Responses were used to
i) calculate an individual’s risk of developing the cancers
specified below; and ii) contextualise findings from the
subsequent interviews. All those with a previous diagnosis
of cancer were advised at this stage that the risk algorithms
being used had not been tested in those with a previous
diagnosis of cancer and so might either underestimate or
overestimate their risk. Socioeconomic status was com-
puted using the participants’ postcode and the English in-
dices of deprivation 2010 available online [33].
Calculation of risk
To calculate the absolute and relative risk of individual
cancers for each participant we adapted the risk algo-
rithms used in the “YourDiseaseRisk” models [13] for
11 cancers (female breast, colorectal, stomach, bladder,
prostate, kidney, melanoma, ovarian, lung, pancreatic,
and uterine) for the UK population. These models were
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chosen as they have a consistent approach across multiple
cancer sites. Full details of the method used to adapt the
algorithms are published elsewhere [34]. In brief, we first
estimated the prevalence in the UK population for each of
the risk factors related to each cancer type and used that
data alongside the “YourDiseaseRisk” algorithms to calcu-
late an individual’s risk of developing each of the cancers
relative to the average UK population.
To enable calculation of the 10-year estimated abso-
lute risk for all 11 cancers we used the “Current Prob-
ability” method [35] based on data from the Cancer
Research UK website [36] for age- and sex-specific can-
cer incidence and data from the Office of National Sta-
tistics [37] for age- and sex-specific death rates from all
causes. This allowed us to estimate the average age- and
sex-specific UK 10-year absolute risk for each cancer
and we multiplied this by each individual’s relative risk
to obtain the estimated 10-year risk for individuals.
Presentation of risk
To enable communication of the risk to participants we
developed a web-based tool that presented the estimated
risk for each cancer either individually or alongside others.
In order to choose the formats in which to present the risk
we first reviewed published literature [27, 38–40] and the
internet to compile an inventory of different formats
currently in use for cardiovascular disease and cancer.
Informed by best practice guidance for communication of
risk [41, 42] we then met with patient and public repre-
sentatives to discuss a range of formats and choose those
to use for the study.
The chosen formats are shown in Fig. 1. They are: a)
absolute 10-year percentage risk on a vertical thermom-
eter scale in grey-scale; b) absolute 10-year percentage risk
on a vertical thermometer scale coloured from green to
red; c) absolute 10-year percentage risk as a coloured bar
chart shaded; and d) relative 10-year risk on a qualitative
scale from ‘Low risk’ to ‘High risk’. All participants were
shown the formats in the same order for either breast or
colorectal cancer to allow us to assess the impact of colour
over a grey-scale image. In all formats participants were
given the opportunity to select changes to their lifestyle
such as those shown in panel e of Fig. 1 and see the im-
pact of those changes on the calculated risk of that cancer.
They were then given the option to view up to six cancers
of their choice from those available simultaneously.
Fig. 1 Formats of risk presention. a) absolute 10-year percentage risk on a vertical thermometer scale in grey-scale; b) absolute 10-year percent-
age risk on a vertical thermometer scale coloured from green to red; c) absolute 10-year percentage risk as a coloured bar chart; d) relative 10-
year risk on a qualitative scale from low to high; e) options to see the impact of changes to lifestyle on risk provided alongside each risk format
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Participants with a previous diagnosis of cancer were not
given the option to see their risk of that specific cancer.
Data collection
The one-to-one face-to-face interviews were conducted by
one of two female researchers (JUS, an academic GP or
BS, a psychologist; both with PhDs and experience of
conducting qualitative research) and, depending on the
participant’s preference, held either in the participant’s
home (n = 11) or in a room at the University of Cambridge
(n = 16). The interviews were semi-structured and based
on a schedule covering their views on receiving persona-
lised risk information in general, of different representa-
tions of that risk, the potential for motivating lifestyle
change, and the timing and site of delivery of the informa-
tion (see Additional file 1). Each lasted between 20 and
50 min and at the end of each interview the participants
were offered a summary of their risk of the individual can-
cers and Cancer Research UK leaflets on how to reduce
their risk and how to recognise signs and symptoms of
cancer. The background of the researchers was not dis-
cussed during the interviews.
Analysis
The interviews were audio-recorded and transcribed ver-
batim and analysed using thematic analysis [43] and the
one sheet of paper (OSOP) method [44]. After approxi-
mately half of the interviews had been completed, the
transcripts were first read and re-read by three researchers
(a UK academic GP, a health psychologist and a social
scientist). A coding frame (available from the authors)
based on the transcripts and the interview schedule and
informed by relevant concerns in the literature was devel-
oped by those same researchers. One researcher (a UK
academic GP) then coded all the transcripts with the aid
of NVivo software (QSR International, version 10). Once
coding was complete, we created a written summary of
the data for each code using the OSOP (one sheet of
paper) method where every section of data relevant to that
code from all the interviews was noted. These were dis-
cussed amongst the wider research team to identify the
key themes first within each code and then across the en-
tire dataset and any outlying views. These summaries were
added to as further data were collected and once all data
had been collected and summarised we then explored
these themes in depth, looking for any patterns across dif-
ferent ages, sexes, current lifestyle habits, and personal
and family history. Throughout the text illustrative quotes
are identified by sex and age group.
Results
We conducted interviews with 27 participants. The
demographic and selected lifestyle characteristics of the
participants are shown in Table 1. 11 were male and 16
Table 1 Characteristics of participants who took part in interviews
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female and the mean age was 49 ± 23 years. Most were
white British from areas of low deprivation with no per-
sonal or family history of cancer and high levels of edu-
cation. The majority were already physically active
though half had a BMI of over 25 kg/m2 and half did
not meet the recommendation of eating five or more
servings of fruit or vegetables per day [45]. When asked
about their views on cancer risk prior to the study, ap-
proximately half reported they were concerned about
their own risk of cancer whilst the other half were ei-
ther not concerned or had not really thought about it.
Initial reaction
The first reaction of almost all participants to being pre-
sented with their 10-year absolute risk of either breast or
colon cancer in grey-scale was that it was low and they
were either reassured or happy with the results and not
concerned or worried.
“Well, it’s not even 1%. I just think that’s really good,
out of 100%, I don’t really need to worry about colon
cancer, that’s what I would say.” (F,30–40).
In some cases these impressions were clearly related
just to the fact that the number was small or to the pos-
ition on the scale rather than an appreciation of the
meaning of the number itself.
“Good, I’m relieved. Just seems a low number. I don’t
know whether it is or not, but, is it a low number?”
(M,>60).
“Okay, that’s quite low then... ‘cos it’s at the very
bottom of the scale. Yeah, it’s at the bottom so quite
happy with that.” (F,20–30).
Only one participant thought the risk was fairly high
and higher than they had expected.
Perception of what would be high risk
When asked what would constitute a high risk for them
there was a wide range of responses from 0.5% to 60%.
The most common were 10% (n = 7), 20% (n = 4), 5% (n
= 3), and 1% (n = 3) which together accounted for over
half of the responses. There was no association with age
or deprivation.
Particularly noticeable was the finding that over half
were unclear about why they had chosen the number
they had. Some individuals were explicit in saying that
they just liked the sound of the numbers they chose
whilst others found it difficult to explain their reasoning.
“I don’t know, it’s just something that, yeah, the
number that just came into my head” (F,30–40).
A small number of participants related it to something
in daily life or other diseases. In general, those who related
it to something specific tended to choose lower, more ac-
curate, numbers than those who didn’t.
“1% is quite a high risk for many things that, if you
don't have to take it you wouldn't take it. I mean,
would you choose to cross the road if one time in a
hundred it happened? No, you'd find a different way.”
(M,30–40).
“I would have probably compared it to cardiovascular
disease risk which would be, currently it’s 10% over 5
years isn’t it I think so I guess I would have viewed it
as the same figure for cancer.” (M,>60, history of
cancer).
Views on format of risk presentation
Preference for colour
Most participants had a preferred format of risk presen-
tation but approximately equal numbers preferred the
coloured thermometer, the bar chart and the relative risk
scale. There was, however, a clear preference for colour,
and for many the addition of colour dominated inter-
pretation of the number.
“If it’s on the green I’m like “Phew, that’s good that”…I
didn’t even need to look at that percentage.” (F,40–60).
Notably two participants did not like colour. One felt
it was ‘childish’ and potentially gave conflicting informa-
tion if the number was low but coloured red and the
other felt that by adding colour we were deliberately try-
ing to manipulate their interpretation and that made
them ‘sceptical’ about the risk.
Benefits of being able to demonstrate change
All participants were enthusiastic about being able to
interact with the risk scores and visually see the poten-
tial impact of changes in lifestyle.
“If you can physically see that that moving down and
knowing that, okay, at the moment my risk is say half
a percent, if I reduce the amount of red meat that I
eat I’ll go down to 0.25% then that’s a good
motivational thing to make me do that.” (F,30–40).
In particular it was felt to be helpful to enable them to
choose which aspect of their lifestyle they should focus
on first.
“If I was to lose weight it’s making a difference of about
0.5, and what would be interesting if I then combine
that with less meat I get a bigger saving obviously, if I
do less meat on its own I get about the same. What
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I’m trying to see is, you know, there’s five factors and
each one of them is an improvement but I don’t want
to become a monk and I could probably do two of
them, which would be best two to do?” (M,40–60).
A few participants suggested that it would also be
helpful to show the effect of unhealthy choices so
they could see what effect their current healthy life-
style was having and what would happen if they
stopped exercising or put on weight, for example. An-
other participant felt having smaller increments of
change might help those needing to make large
changes. For example including an hour of physical
activity per week rather than just the recommended
three hours.
Absolute versus relative risk
Almost all participants responded positively to seeing
their risk relative to people of their age and sex in the
UK population as it enabled them to put their risk ‘into
perspective’. Two participants, however, were not inter-
ested in comparing themselves to others as they consid-
ered their risk personal to them.
“I don’t know that I would prefer it, I would say it’s useful
information, but I think to me personally I am not really
fussed where I am compared to average…” (F,30–40).
Individual versus multiple cancers
All participants liked being able to see their risk of
multiple individual cancers alongside each other and
spent time during the interviews selecting and dese-
lecting cancers and lifestyle options to compare their
risk of different cancers and the effects of lifestyle
changes. Notably many had specific cancers that they
were most interested in, often those which had af-
fected family members or friends. When asked
whether they preferred to see them individually or
combined, a small number felt strongly that they
would prefer individual cancers because ‘different can-
cers are caused by different things’ (F,>60) or just one
combined risk because they ‘didn’t distinguish differ-
ent types of cancer’ (M,30–40) and felt all cancers
were bad so were primarily interested in reducing
their overall risk. The majority expressed preference
for both an overall combined risk and the option to
look at individual cancers.
“I think it would be nice to have combined risk but if
you break it down to individual you can then see
which cancer has got the highest risk and then you can
then from that choose to change your lifestyle to
reduce that, so you can reduce that particular one.”
(M,>60).
Potential for personalised cancer risk information to
motivate behaviour change
Most participants felt personalised cancer risk infor-
mation would help others to make changes to their
lifestyle.
“I definitely think it's helpful and I think it's gonna
really motivate people to make changes because, yeah,
cancer's scary and if you see that your risk can drop it,
yeah, I think it might really motivate people to make
changes.” (F,30–40).
A number also reported intentions to change their
own behaviour after receiving their personalised cancer
risk. For some this was because seeing their risk reaf-
firmed plans for changes they had already been consider-
ing. For others the motivation came directly from now
wanting to lower their risk.
“... for me it reaffirms that my choices and changes
that I’d like my lifestyle and it’s actually in the right
direction and it will certainly help me to stick to them
and continue with these choices for the perceived
future.” (M,30–40).
“It motivates me now to decrease my risk.….I will try
to start lifestyle changes now, yes….I’d like to lose some
weight, and eat, you know, healthily.” (F,30–40).
There were also several who described a balance with
some things being easier to achieve and so possible at a
lower risk and some that would require a higher risk in
order to motivate them.
“Reduce red meat, I guess I could try, maybe I would,
so I would think, okay, so that’s my risk but it says less
than three servings per week, I could do that I think or
at least get a, go towards that, you know….. Eat the
vegetables no, I’m afraid not.” (F,40–60).
However, for many, receiving their personalised
cancer risk did not influence their intention to
change their behaviour. Reasons for this fell into
three groups (Table 2). The first, and most common,
was that the risk was perceived to be so low that re-
ducing it further was not a priority. The second, who
tended to be those with the lowest risk, were reas-
sured that they were already living a healthy lifestyle
and so did not feel they needed to make any
changes. The third group were older participants
who felt that it was too late to start worrying about
cancer, either because they felt it was simply too late
to change or because they accepted that they had to
die from something.
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Views on provision of cancer risk information generally
All participants were supportive of offering cancer risk in-
formation more widely and would recommend it to their
family and friends. There was a clear distinction between
offering and providing though, with recognition that it
should be up to the individual and may not be appropriate
for everyone, particularly those who are already very
health-conscious.
When asked how they would prefer to receive this
information outside the context of a research study
the majority expressed a preference for face-to-face
with the others preferring it online or online with the
option to discuss it face-to-face. Reasons participants
gave for preferring face-to-face delivery were that it
provided an opportunity to ask questions and confirm
their interpretation and that looking at it at home
alone for the first time had the potential to be scary
and cause panic. Some also felt receiving the risk in
person was more likely to motivate people to make
changes to their lifestyle.
“I think face-to-face is better you know in a general
sense for any communication, just from my experience
I think whatever you do, face-to-face is much more, it’s
more likely to make it have an effect I think.” (M,>60,
history of cancer).
Many mentioned their Primary Care physician (PCP)
or other primary care healthcare professionals as the
most appropriate people to deliver the information.
However, several were concerned that PCPs would not
have the time or should focus on other aspects of care.
There was a general view though that, if the information
was not being given face to face by the their PCP or an-
other health care professional, it needed to be endorsed
by the PCP to provide credibility.
Discussion
Most previous studies to date in this area have fo-
cused on preferences for different formats of presen-
tation using hypothetical examples [27–30] or on
measuring accuracy of perceived risk after provision
of risk information [9, 46–48]. By providing individ-
uals with their own personalised risk estimate within
the context of a research interview, this study pro-
vides novel insights into the reactions of the general
public to receiving their personalised estimated risk of
cancer. We found that participants generally viewed
receiving this information positively and were keen
that it be provided more widely. When presented with
their 10-year absolute risk of an individual cancer on
a grey-scale almost all felt that it was low and not
concerning. Views on what constituted a high risk
ranged widely, from 0.5 to 60%. When presented in
colour, the colour was often more important than the
number and dominated their interpretation but there
was no clear preference for one format of presenta-
tion. All felt seeing the impact of changes in lifestyle
on their risk was helpful. For some this led to inten-
tions to change behaviour, but reductions in risk were
not always motivating as the risks were considered
low and differences small.
Table 2 Reasons for not expressing any intention to change behaviour
Reasons for not expressing any intention to change behaviour
Risk so low “So that’s interesting, you’re right, I could get it down to absolutely zero if I lived as a hermit,
and I think that’s the point..… if my risk factor was very high, very high, I would probably
do something about it, but because it’s so low, then actually getting it even lower with
having to do significant things to my lifestyle, then I probably wouldn’t. There, that’s my
balance.” (M,40–60)
“I mean all of the values are in some ways very theoretical because it’s all low risk and I
suppose I’m not doing anything that is considered high risk, so I would probably not, so
not be worried by the things I’ve seen and sort of spurned on to make lots of changes
because it’s all low risk.” (F, 30–40)
Reassured that already living a healthy lifestyle “I’m pretty happy with my low risk of cancer and I’ll just keep doing as I have been doing
with my lifestyle behaviours.” (F,20–30)
“I mean very informative and I think everybody should know these risks, but for me it’s
not rung alarm bells, I just keep on, keep on eating healthy, keep on exercising regularly
and having a good balanced lifestyle, etc., etc.,”. (F,40–60)
Not worried about risk – too late at my age “I think it’s too late probably, when I was 50 it would be different but now I think it’s too
late to change much”. (F,>60)
“I wouldn’t think of doing anything about it because at my stage of life, let’s suppose
there was alright a 10% chance that within the next 10 years I’ll get cancer and we think,
right, I can avoid that by doing A, B and C but thank you, what are the other options
because I’m going to get one of them, so that’s why it doesn’t worry me on the basis that
I’m assuming there is at least a 1 in 10 chance if not higher I will die within the next
10 years, so you start looking at what am I going to die of and my immediate reaction is
I don’t see I can be confident that the alternatives will be less unpleasant.” (M,>60)
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Perhaps the most important of these findings is that
whilst many of the participants described how their
intention to change their behaviour was influenced by
their risk, a finding consistent with many behavioural
theories, they appeared to be influenced less by a spe-
cific image of their cumulative chance of cancer and
more by a sense of what is a “significant” number in gen-
eral. As a result, many had very high thresholds compared
to the estimated risks of individual cancers. Improving
accuracy of risk perception alone may, therefore, not
influence behaviour and the need for either relative risk
information or colour grading to provide context for
interpretation of risk [27, 28] is particularly important for
cancer when risks are generally low.
The finding that there was no clear preference for the
format of risk presentation is consistent with other
studies in which participants were provided risk of cancer
or cardiovascular disease in different formats [27–29] and
highlights the need for a range of individualised presenta-
tions that take into account the numeracy and graph liter-
acy of the audience [42]. As in those studies, there was,
nevertheless, a clear preference for colour with green seen
as safe regardless of the number [28].
Being able to see the impact of changes in lifestyle was
felt to be useful by participants, especially in being able to
prioritise particular forms of behaviour change. For some,
this either supported existing lifestyle choices or encour-
aged them to introduce new changes. This is consistent
with existing research which has demonstrated an associ-
ation between response efficacy, the belief that an interven-
tion or action is effective against a perceived health threat,
and intention to change behaviour [49–52]. The provision
of cancer risk information may, therefore, be a useful tool
to promote intentions for behaviour change for cancer pre-
vention in some individuals but this requires further con-
firmation from studies with quantitative study designs.
Limitations
These findings must, additionally, be interpreted with con-
sideration of the limitations of the study. The main limita-
tion is that, by definition, the participants were a small,
self-selected group interested in their cancer risk as they
had responded to invitations to take part in a research
study to help the development of personalised cancer risk
tools. We attempted to reduce this bias by using three
different recruitment strategies and approximately half of
the final sample reported either not being concerned
about their cancer risk prior to the study or having not
really thought about it. Nevertheless we cannot exclude
the possibility that the self-selected nature of the sample
impacted on the results. The sample also included partici-
pants with a wide range of ages and three participants
with a history of cancer. This was a deliberate decision at
the time of recruitment in order to capture the views of
all those to whom cancer risk may be provided in the fu-
ture, including those with a diagnosis of cancer where
there is increasing evidence that lifestyle change can im-
prove survival [53–55] as well as prevent a second cancer.
Whilst we did not see a clear difference in the views across
the different groups, it remains possible that the views
of younger participants may change as they get older
and those with a personal history of cancer may inter-
pret risk quite differently depending on the cancer they
survived. Those with a previous history of cancer were
also told that the risk scores had not been tested in
people with experience of cancer and so the meaning of
the estimated risks to them may have been different
from those without a history of cancer. The effect of the
presentation of risk on intention to change behaviour may
also have been limited by the characteristics of the partici-
pants. Most were from areas of low deprivation, were
highly educated and were already achieving the physical
activity recommendations. Instead of focusing on their
own lifestyle, many instead also discussed how useful they
thought it would be for other people. This response may
have been supported by knowing they were taking part in
a study to discuss different ways of presenting cancer risk.
Conclusions
Overall, our findings show that, amongst the participants of
this study, provision of personalised cancer risk information
was well received and may be a useful adjunct to other can-
cer prevention initiatives. The wide range of views on what
constitutes a high risk highlights the need for further work
to address the disparity between typical risk estimates of in-
dividual cancers and the general perception of what consti-
tutes a risk high enough to motivate behaviour change. In
addition, this study suggests that when risks of cancer are
presented without context many people are likely to con-
sider them low and not concerning. The use of colour can
help but the choice of colours need careful consideration.
Alternatively, providing patients with the risks of other dis-
eases or life events may help patients contextualise a less
well known health risk by providing a frame of reference.
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